Literature DB >> 35986199

Bystander LECT2 amyloidosis in tumor nephrectomy.

A J Gallan1, B Bhasin-Chhabra2, D Kilari3, S Johnson4, A D'Souza3.   

Abstract

Pathologic evaluation of the non-neoplastic renal parenchyma in tumor nephrectomy specimens is critical and can detect both renal-limited and systemic pathologies. We report the case of a 69-year-old Punjabi male who underwent cytoreductive nephrectomy for advanced renal cell carcinoma after immunotherapy. We detected clinically unexpected leukocyte chemotactic factor 2 (LECT2) amyloidosis during pathologic analysis of the surrounding non-neoplastic renal parenchyma, which was confirmed by mass spectrometry. LECT2 amyloidosis occurs predominantly in Hispanic patients and has only rarely been described in Punjabi patients. This case highlights the importance of careful pathologic evaluation of the non-neoplastic renal parenchyma of nephrectomy specimens and raises awareness that LECT2 amyloidosis can occur outside of the typical demographic of Hispanic patients.
© 2022. The Author(s) under exclusive licence to The Japan Society of Nephrology.

Entities:  

Keywords:  Amyloidosis; LECT2; Nephrectomy; Onconephrology; Punjabi; Renal cell carcinoma; Renal pathology

Year:  2022        PMID: 35986199     DOI: 10.1007/s13730-022-00728-9

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  24 in total

Review 1.  Molecular mechanisms of amyloidosis.

Authors:  Giampaolo Merlini; Vittorio Bellotti
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

Review 2.  Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics.

Authors:  Samih H Nasr; Ahmet Dogan; Christopher P Larsen
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-14       Impact factor: 8.237

3.  Leukocyte chemotactic factor 2: A novel renal amyloid protein.

Authors:  Merrill D Benson; Sam James; Katherine Scott; Juris J Liepnieks; Barbara Kluve-Beckerman
Journal:  Kidney Int       Date:  2008-04-30       Impact factor: 10.612

4.  Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors.

Authors:  Alexander J Gallan; Ellen Alexander; Pankti Reid; Fouad Kutuby; Anthony Chang; Kammi J Henriksen
Journal:  Am J Kidney Dis       Date:  2019-06-14       Impact factor: 8.860

5.  Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies.

Authors:  Christopher P Larsen; Patrick D Walker; Deborah T Weiss; Alan Solomon
Journal:  Kidney Int       Date:  2010-02-24       Impact factor: 10.612

6.  Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.

Authors:  Vanesa Bijol; Gonzalo P Mendez; Shelley Hurwitz; Helmut G Rennke; Vânia Nosé
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

Review 7.  Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated.

Authors:  Kammi J Henriksen; Shane M Meehan; Anthony Chang
Journal:  Arch Pathol Lab Med       Date:  2009-07       Impact factor: 5.534

8.  Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Authors:  Frank B Cortazar; Kristen A Marrone; Megan L Troxell; Kenneth M Ralto; Melanie P Hoenig; Julie R Brahmer; Dung T Le; Evan J Lipson; Ilya G Glezerman; Jedd Wolchok; Lynn D Cornell; Paul Feldman; Michael B Stokes; Sarah A Zapata; F Stephen Hodi; Patrick A Ott; Michifumi Yamashita; David E Leaf
Journal:  Kidney Int       Date:  2016-06-07       Impact factor: 10.612

9.  Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases.

Authors:  Kammi J Henriksen; Shane M Meehan; Anthony Chang
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

10.  Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.

Authors:  Merrill D Benson; Joel N Buxbaum; David S Eisenberg; Giampaolo Merlini; Maria J M Saraiva; Yoshiki Sekijima; Jean D Sipe; Per Westermark
Journal:  Amyloid       Date:  2020-10-26       Impact factor: 7.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.